Failure to find an association between hepatitis C virus and thyroid autoimmunity

Thyroid

Volumn 7, Issue 3, 1997, Pages 421-424

  Metcalfe, R A ^a   Ball, G ^b   Kudesia, G ^b   Weetman, A P ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; DISEASE ASSOCIATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HASHIMOTO DISEASE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFECTION RISK; PRIORITY JOURNAL; THYROID GLAND; VIRUS INFECTION;

EID: 0030750655     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.421     Document Type: Article

References (29)

1. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 15:788-830.
2. Tomer Y, Davies TF 1993 Infection, thyroid disease, and autoimmunity. Endocr Rev 14:107-115.
3. Coyle PV, Wyatt D, Connolly JH, O'Brien C 1989 Epstein-Barr virus infection and thyroid dysfunction. Lancet i:899.
4. Ciampolilo A, Marini V, Mirakian R, Buscema M, Schulz T, Pujol-Borrell R, Bottazzo GF 1989 Retrovirus-like sequences in Graves' disease: Implications for human autoimmunity. Lancet i:1096-1099.
5. Tominaga T, Katamine S, Namba H, Yokoyama N, Nakamura S, Morita S, Yamashita S, Izumi M, Miyamoto T, Nagataki S 1991 Lack of evidence for the presence of human immunodeficiency virus type 1-related sequences in patients with Graves' disease. Thyroid 1:307-314.
6. Humphrey M, Baker JR, Carr FE, Wartofsky L, Mosca J, Drabick JJ, Burke D, Djuh YY, Burman ID 1991 Absence of retroviral sequences in Graves' disease. Lancet 337:17-18.
7. Lagaye S, Vexiau P, Morozov V, Guénebaut-Claudet V, Tobaly-Tapiero J, Canivet M, Cathelineau G, Périès J, Emanoil-Ravier R 1992 Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves' disease. Proc Natl Acad Sci USA 89:10070-10074.
8. Wick G, Grubeck-Loebenstein B, Trieb K, Kalischnig G, Aguzzi A 1992 Human foamy virus antigens in thyroid tissue of Graves' disease patients. Int Arch Allergy Immunol 99:153-156.
9. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D 1994 Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses 10:601-605.
10. Tran A, Quaranta JF, Beusnel C, Thiers V, De Souza M, François E, Hébuterne X, Rampal P 1992 Hepatitis C virus and Hashimoro's thyroiditis. Eur J Med 1:116-118.
11. Quaranta JF, Tran A, Régnier D, Letestu R, Beusnel C, Fuzibet J-G, Thiers V, Thiers V, Rampal P 1993 High prevalence of antibodies to hepatitis C virus (HCV) in patients with antithyroid autoantibodies. J Hepatol 18:136-138.
12. Duclos-Vallée JC, Johanet C, Trinchet JC, Deny P, Laurent MF, Duron F, Valensi P, Weil B, Homberg JC, Pateron D, Beaugrand M 1994 High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. Br Med J 309:846-847.
13. Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, Kumahara Y 1978 Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab 46:859-862.
14. Leri O, Sinopoli MT, Di Prima MA 1995 Hepatitis C virus antibodies and Graves' disease. Br Med J 310:128-129.
15. Irving WL, Neal KR, Underwood JCE, Simmonds PN, James V on behalf of Trent Regional Hepatitis C Virus Study Group 1994 Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Br Med J 308:695-696.
16. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R 1991 Antibodies to hepatitis C virus in autoimmune liver disease: Evidence for geographical heterogeneity. Lancet 338:277-280.
17. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R 1990 Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 335:754-757.
18. Volpé R 1995 The immune system and its role in endocrine function. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. 2nd Edition. JB Lippincott Co, Philadelphia, pp. 1629-1641.
19. Zaaijer HL, Cuypers HIM, Reesink HW, Winkel IN, Gerken G, Lelie PN 1993 Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.
20. Yun ZB, Lindh G, Weiland O, Johansson B, Sönnerborg A 1993 Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. J Med Virol 39:57-61.
21. Follett EAC, Dow BC, McOmish F, Lee Yap P, Hughes W, Mitchell R, Simmonds P 1991 HCV confirmatory testing of blood donors. Lancet 338:1024.
22. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley-Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET 1995 The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol 43:55-68.
23. Nordyke RA, Gilbert JR FI, Miyamoto LA, Fleury KA 1993 The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 153:862-865.
24. Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, Del Ninno E, Meroni PL, Colombo M, Beck-Peccoz P 1995 Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha 2-a. Eur J Endocrinol 132:587-593.
25. Chung YH, Shong YK 1993 Development of thyroid autoimmunity after administration of recombinant human interferon-α2b for chronic viral hepatitis. Am J Gastroenterol 88:244-247.
26. Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch JP, Lemmonier C, Benhamou JP, Bock B 1993 Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 39:657-661.
27. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier, P, Regnier D, Dreyfus G, Pradier C, Sadoul JL, Hébuterne X, Rampal P 1993 High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:253-257.
28. Imagawa A, Itoh N, Hanafusa T, Oda Y, Waguri M, Miyagawa JI, Kono N, Kuwajima M, Matsuzawa Y 1995 Autoimmune endocrine disease induced by recombinant interferon-α therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 80:922-926.
29. Boadas J, Rodriguez-Espinosa J, Enriquez J, Miralles F, Martinez-Cerezo FJ, Gonzalez P, Madoz P, Vilardell F 1995 Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 22:611-615.